Nachrichten zur Personalis Inc. Aktie

Personalis (PSNL) hat sich als Diagnostikunternehmen auf die Präzisionsonkologie spezialisiert. Eines der Kernprodukte ist NeXT Personal, das zur Erkennung minimaler…

…

…

…

We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article,…

…

The Global Gene Panel Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Gene Panel Market…

…

Myriad Genetics (MYGN) inks an agreement with Personalis to cross-license patent estates covering tumor-informed approaches to detect minimal residual disease.…

Personalis executive sells $1,297 in company stock…

Personalis Inc executive sells over $2,300 in stock…

…

Needham raises Personalis stock target to $3.50, maintains buy rating…

…